Effects of unfractionated heparin on expression of metalloproteinase-2 and -9 in acute lung injury rats

( views:301, downloads:0 )
Author:
LI Xu(Department of Intensive Care Unit, the First Affiliated Hospital of China Medical University, Shenyang 110001, Liaoning, China)
ZHENG Zhen(Department of Intensive Care Unit, the First Affiliated Hospital of China Medical University, Shenyang 110001, Liaoning, China)
MA Xiao-chun(Department of Intensive Care Unit, the First Affiliated Hospital of China Medical University, Shenyang 110001, Liaoning, China)
Journal Title:
Chinese Critical Care Medicine
Issue:
Volume 24, Issue 10, 2012
DOI:
10.3760/cma.j.issn.1003-0603.2012.10.010
Key Word:
Acute lung injury; Unfractionated heparin; Matrix metalloproteinase-2; Matrix metalloproteinase-9

Abstract: Objective To determine the activation of matrix metalloproteinase (MMP-2,MMP-9 ) in rats with acute lung injury (ALI) and the effects of unfractionated heparin (UFH) on the levels.Methods Eighteen male Wistar rats were divided into control group,ALI group and UFH group,with 6 rats in each group by means of random number table.ALI was induced by administering a bolus injection of lipopolysaccharide ( LPS ) via the caudal vein at a dose of 6 mg/kg.In UFH group the rats were treated intravenously with 100 U/kg of UFH 15 minutes before the injection of LPS.In control group,the rats were treated with the same volume of normal saline.Serum levels of MMP-2 and MMP-9 were measured by onzymelinked immunosorbent assay (ELISA) at 1,3,6 hours via femoral vein.Six hours after the injection of reagents,the rats were sacrificed and lung tissue samples were collected for mRNA analysis of the MMP-2 and MMP-9 by real-time fluorescence quantitate reverse transcription-polymerase chain reaction (qRT-PCR).Results Compared with control group,the content of MMP-2 (μg/L) and MMP-9 (μg/L) in serum of ALI group were increased,and reached the peak at 6 hours (MMP-2:2.86 ± 0.40 vs.1.21 ± 0.24,MMP-9:2.54 ± 0.29 vs.1.15 ±0.34,both P<0.01); they were down-regulated in UFH group at 6 hours (MMP-2:1.92 ± 0.31 vs.2.86 ± 0.40,MMP-9:1.82 ± 0.26 vs.2.54 ± 0.29,both P<0.05).Compared with control group,the mRNA expressions of MMP-2 and MMP-9 in the lung tissue of ALI group were increased at 6 hours (MMP-2 mRNA:1.88 ± 0.09 vs.1.00 ± 0.10,MMP-9 mRNA:3.15 ± 0.47 vs.1.00 ± 0.17,both P<0.01); they were down-regulated in UFH group (MMP-2mRNA:1.26 ± 0.14 vs.1.88 ± 0.09,P<0.01 ; MMP-9 mRNA:2.06 ± 0.68 vs.3.15 ± 0.47,P<0.05 ),but still above the control group (both P<0.05 ).Conclusions The present study demonstrated that the level of MMP-2 and MMP-9 increased in rats with ALI.UFH could exert protective effects by inhibiting expression of MMP-2 and MMP-9 in serum and lung tissue,in both mRNA and protein expression.

  • [1]Brinckerhoff CE,Matrisian LM.Matrix metalloproteinases:a tail of a frog that became a prince.Nat Rev Mol Cell Biol,2002,3:207-214.
  • [2]Lanchou J,Corbel M,Tanguy M,et al.Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients.Crit Care Med,2003,31:536-542.
  • [3]马晓春,李旭.肝素在脓毒症治疗中的应用前景.中国危重病急救医学,2010,22:566-569.
  • [4]Liu D,Zeng BX,Zhang SH,et al.Rosiglitazone,a peroxisome proliferator-activated receptor-gamma agonist,reduces acute lung injury in endotoxemic rats.Crit Care Med,2005,33:2309-2316.
  • [5]Martin GS,Mannino DM,Eaton S,et al.The epidemiology of sepsis in the United States from 1979 through 2000.N Engl J Med,2003,348:1546-1554.
  • [6]Ware LB.Pathophysiology of acute lung injury and the acute respiratory distress syndrome.Semin Respir Crit Care Med,2006,27:337-349.
  • [7]Laterre PF,Wittebole X,Dhainaut JF.Anticoagulant therapy in acute lung injury.Crit Care Med,2003,31:S329-336.
  • [8]Czabanka M,Peter C,Martin E,et al.Microcirculatory endothelial dysfunction during endotoxemia-insights into pathophysiology,pathologic mechanisms and clinical relevance.Curr Vase Pharmacol,2007,5:266-275.
  • [9]Bernard GR,Vincent JL,Laterre PF,et al.Efficacy and safety of recombinant human activated protein C for severe sepsis.N Engl J Med,2001,344:699-709.
  • [10]陈松,马晓春.肝素对脓毒症大鼠静脉血白细胞介素-6、肿瘤坏死因子-α和血管紧张素Ⅱ表达的影响.中国危重病急救医学,2010,22:555-558.
  • [11]Tyrell DJ,Kilfeather S,Page CP.Therapeutic uses of heparin beyond its traditional role as an anticoagulant.Trends Pharmacol Sci,1995,16:198-204.
  • [12]Morrison AM,Wang P,Chaudry IH.A novel nonanticoagulant heparin prevents vascular endothelial cell dysfunction during hyperdynamic sepsis.Shock,1996,6:46-51.
  • [13]Freischlag JA,Colbum MD,Qui(n)ones-Baldrich WJ,et al.Alteration of neutrophil (PMN) function by heparin,dexamethasone,and enalapril.J Surg Res,1992,52:523-529.
  • [14]Yagmurdur MC,Turk E,Moray G,et al.Effects of heparin on bacterial translocation and gut epithelial apoptosis after bum injury in the rat:dose-dependent inhibition of the complement cascade.Bums,2005,31:603-609.
  • [15]Abubakar K,Schmidt B,Monkman S,et al.Heparin improves gas exchange during experimental acute lung injury in newborn piglets.Am J Respir Crit Care Med,1998,158:1620-1625.
  • [16]Cepkova M,Matthay MA.Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome.J Intensive Care Med,2006,21:119-143.
  • [17]栾正刚,娜拉·普鲁,章志丹,等.低分子肝素和阿司匹林对急性肺损伤的治疗作用.中国危重病急救医学,2006,18:456-458.
  • [18]汪宗昱,杨拔贤,朱曦,等.普通肝素雾化吸入对内毒素性肺损伤大鼠肺泡局部凝血及炎症反应的影响.中国危重病急救医学,2011,23:239-242.
  • [19]赵聪,章志丹,张晓娟,等.小剂量肝素治疗脓毒症的临床分析.中华内科杂志,2009,48:566-569.
  • [20]韩旭东,黄晓英,葛志华,等.持续小剂量肝素治疗脓毒症患者急性肺损伤/急性呼吸窘迫综合症的临床研究.临床肺科杂志,2010,15:1730-1732.
  • [21]Nagase H.Activation mechanisms of matrix metalloproteinases.Biol Chem,1997,378:151-160.
  • [22]Carden D,Xiao F,Moak C,et al.Neutrophil elastase promotes lung microvascular injury and proteolysis of endothelial cadherins.Am J Physiol,1998,275:H385-392.
  • [23]Suga M,lyonaga K,Okamoto T,et al.Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias.Am J Respir Crit Care Med,2000,162:1949-1956.
  • [24]Foda HD,Rollo EE,Drews M,et al.Ventilator-induced lung injury upregulates and activates gelatinases and EMMPRIN:attenuation by the synthetic matrix metalloproteinase inhibitor,Prinomastat (AG3340).Am J Respir Cell Mol Biol,2001,25:717-724.
  • [25]Volman TJ,Goris RJ,Lomme RM,et al.Increased expression of matrix meialloproteinases in the murine zymosan-induced multiple organ dysfunction syndrome.J Pathol,2004,203:968-975.
  • [26]Dubois B,Starckx S,Pagenstecher A,et al.Gelatinase B deficiency protects against endotoxin shock.Eur J Immunol,2002,32:2163-2171.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn